home All News open_in_new Full Article

Beijing tackles drug price wars with new tendering rules in anti

Beijing’s new rules for state-led bulk tendering of medical drugs are the latest example of its “anti-involution” drive to combat cutthroat competition, a move analysts said would favour more established players. “The centralised bulk procurement rules optimisation is a sign that the National Healthcare Security Administration is proactively pushing Beijing’s anti-involution agenda within the pharmaceutical sector as part of efforts to bolster domestic consumption,” Guotai Haitong Securities’...


today 4 w. ago attach_file Events

attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events


ID: 3203544164
Add Watch Country

arrow_drop_down